nodes	percent_of_prediction	percent_of_DWPC	metapath
Moclobemide—Bezafibrate—Glyburide—type 2 diabetes mellitus	0.269	1	CrCrCtD
Moclobemide—CYP1A2—type 2 diabetes mellitus	0.191	1	CbGaD
Moclobemide—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0216	0.0582	CbGbCtD
Moclobemide—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0211	0.0569	CbGbCtD
Moclobemide—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0193	0.052	CbGbCtD
Moclobemide—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0184	0.0495	CbGbCtD
Moclobemide—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0184	0.0495	CbGbCtD
Moclobemide—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.018	0.0484	CbGbCtD
Moclobemide—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0169	0.0456	CbGbCtD
Moclobemide—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0164	0.0441	CbGbCtD
Moclobemide—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0156	0.0421	CbGbCtD
Moclobemide—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0153	0.0411	CbGbCtD
Moclobemide—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0153	0.0411	CbGbCtD
Moclobemide—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0141	0.0379	CbGbCtD
Moclobemide—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.014	0.0376	CbGbCtD
Moclobemide—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0136	0.0366	CbGbCtD
Moclobemide—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0129	0.0347	CbGbCtD
Moclobemide—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0124	0.0335	CbGbCtD
Moclobemide—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0123	0.0332	CbGbCtD
Moclobemide—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0116	0.0314	CbGbCtD
Moclobemide—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0116	0.0312	CbGbCtD
Moclobemide—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0111	0.0299	CbGbCtD
Moclobemide—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0106	0.0285	CbGbCtD
Moclobemide—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0101	0.0273	CbGbCtD
Moclobemide—CYP2C19—Glyburide—type 2 diabetes mellitus	0.0094	0.0253	CbGbCtD
Moclobemide—CYP2C19—Losartan—type 2 diabetes mellitus	0.0086	0.0232	CbGbCtD
Moclobemide—CYP1A2—Losartan—type 2 diabetes mellitus	0.00793	0.0214	CbGbCtD
Moclobemide—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00782	0.021	CbGbCtD
Moclobemide—CYP2C9—Losartan—type 2 diabetes mellitus	0.00715	0.0193	CbGbCtD
Moclobemide—Bezafibrate—HMGCR—type 2 diabetes mellitus	0.00067	0.231	CrCbGaD
Moclobemide—Bezafibrate—PPARA—type 2 diabetes mellitus	0.000659	0.227	CrCbGaD
Moclobemide—Procainamide—DNMT1—type 2 diabetes mellitus	0.000523	0.18	CrCbGaD
Moclobemide—Minaprine—HTR2C—type 2 diabetes mellitus	0.000373	0.129	CrCbGaD
Moclobemide—Bezafibrate—PPARG—type 2 diabetes mellitus	0.000316	0.109	CrCbGaD
Moclobemide—MAOB—nerve—type 2 diabetes mellitus	0.000302	0.133	CbGeAlD
Moclobemide—MAOA—nerve—type 2 diabetes mellitus	0.000258	0.113	CbGeAlD
Moclobemide—Bezafibrate—CYP3A4—type 2 diabetes mellitus	0.000136	0.047	CrCbGaD
Moclobemide—Haloperidol—CYP1A2—type 2 diabetes mellitus	0.000133	0.046	CrCbGaD
Moclobemide—MAOA—islet of Langerhans—type 2 diabetes mellitus	0.000125	0.055	CbGeAlD
Moclobemide—MAOB—nephron tubule—type 2 diabetes mellitus	0.000118	0.0519	CbGeAlD
Moclobemide—Palpitations—Metformin—type 2 diabetes mellitus	0.000113	0.000945	CcSEcCtD
Moclobemide—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000113	0.000943	CcSEcCtD
Moclobemide—Shock—Valsartan—type 2 diabetes mellitus	0.000113	0.000943	CcSEcCtD
Moclobemide—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000112	0.00094	CcSEcCtD
Moclobemide—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000112	0.000936	CcSEcCtD
Moclobemide—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000112	0.000936	CcSEcCtD
Moclobemide—Flatulence—Losartan—type 2 diabetes mellitus	0.000112	0.000936	CcSEcCtD
Moclobemide—Tension—Losartan—type 2 diabetes mellitus	0.000111	0.000932	CcSEcCtD
Moclobemide—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000111	0.000931	CcSEcCtD
Moclobemide—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000111	0.00093	CcSEcCtD
Moclobemide—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000111	0.00093	CcSEcCtD
Moclobemide—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000111	0.000928	CcSEcCtD
Moclobemide—Agitation—Irbesartan—type 2 diabetes mellitus	0.000111	0.000927	CcSEcCtD
Moclobemide—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000111	0.000927	CcSEcCtD
Moclobemide—Hypertension—Metformin—type 2 diabetes mellitus	0.00011	0.000923	CcSEcCtD
Moclobemide—Urticaria—Glyburide—type 2 diabetes mellitus	0.00011	0.000923	CcSEcCtD
Moclobemide—Nervousness—Losartan—type 2 diabetes mellitus	0.00011	0.000922	CcSEcCtD
Moclobemide—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.00011	0.000918	CcSEcCtD
Moclobemide—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.00011	0.000918	CcSEcCtD
Moclobemide—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000109	0.000915	CcSEcCtD
Moclobemide—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000109	0.000912	CcSEcCtD
Moclobemide—Myalgia—Metformin—type 2 diabetes mellitus	0.000109	0.00091	CcSEcCtD
Moclobemide—Chest pain—Metformin—type 2 diabetes mellitus	0.000109	0.00091	CcSEcCtD
Moclobemide—Malaise—Irbesartan—type 2 diabetes mellitus	0.000109	0.00091	CcSEcCtD
Moclobemide—Headache—Pioglitazone—type 2 diabetes mellitus	0.000108	0.000906	CcSEcCtD
Moclobemide—Syncope—Irbesartan—type 2 diabetes mellitus	0.000108	0.000905	CcSEcCtD
Moclobemide—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000108	0.000901	CcSEcCtD
Moclobemide—Discomfort—Metformin—type 2 diabetes mellitus	0.000107	0.000899	CcSEcCtD
Moclobemide—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000107	0.000899	CcSEcCtD
Moclobemide—Nausea—Glipizide—type 2 diabetes mellitus	0.000107	0.000896	CcSEcCtD
Moclobemide—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000107	0.000895	CcSEcCtD
Moclobemide—Hypotension—Valsartan—type 2 diabetes mellitus	0.000107	0.000895	CcSEcCtD
Moclobemide—Vision blurred—Losartan—type 2 diabetes mellitus	0.000107	0.000895	CcSEcCtD
Moclobemide—MAOA—retina—type 2 diabetes mellitus	0.000107	0.047	CbGeAlD
Moclobemide—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000107	0.000893	CcSEcCtD
Moclobemide—Constipation—Gliclazide—type 2 diabetes mellitus	0.000106	0.000892	CcSEcCtD
Moclobemide—Tremor—Losartan—type 2 diabetes mellitus	0.000106	0.00089	CcSEcCtD
Moclobemide—Rash—Glimepiride—type 2 diabetes mellitus	0.000106	0.000888	CcSEcCtD
Moclobemide—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000106	0.000887	CcSEcCtD
Moclobemide—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000106	0.000887	CcSEcCtD
Moclobemide—MAOB—cardiovascular system—type 2 diabetes mellitus	0.000106	0.0466	CbGeAlD
Moclobemide—Rash—Sitagliptin—type 2 diabetes mellitus	0.000106	0.000885	CcSEcCtD
Moclobemide—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000106	0.000884	CcSEcCtD
Moclobemide—Headache—Glimepiride—type 2 diabetes mellitus	0.000105	0.000882	CcSEcCtD
Moclobemide—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000105	0.000881	CcSEcCtD
Moclobemide—Headache—Sitagliptin—type 2 diabetes mellitus	0.000105	0.000879	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000104	0.000873	CcSEcCtD
Moclobemide—Agitation—Losartan—type 2 diabetes mellitus	0.000104	0.000873	CcSEcCtD
Moclobemide—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000104	0.000872	CcSEcCtD
Moclobemide—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000104	0.000871	CcSEcCtD
Moclobemide—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000104	0.000869	CcSEcCtD
Moclobemide—Flushing—Ramipril—type 2 diabetes mellitus	0.000104	0.000868	CcSEcCtD
Moclobemide—MAOB—kidney—type 2 diabetes mellitus	0.000103	0.0456	CbGeAlD
Moclobemide—Insomnia—Valsartan—type 2 diabetes mellitus	0.000103	0.000867	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000103	0.000863	CcSEcCtD
Moclobemide—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000103	0.00086	CcSEcCtD
Moclobemide—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000103	0.000859	CcSEcCtD
Moclobemide—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000103	0.000859	CcSEcCtD
Moclobemide—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000103	0.000859	CcSEcCtD
Moclobemide—Shock—Metformin—type 2 diabetes mellitus	0.000102	0.000858	CcSEcCtD
Moclobemide—Insomnia—Orlistat—type 2 diabetes mellitus	0.000102	0.000856	CcSEcCtD
Moclobemide—Malaise—Losartan—type 2 diabetes mellitus	0.000102	0.000856	CcSEcCtD
Moclobemide—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000102	0.000856	CcSEcCtD
Moclobemide—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000102	0.000854	CcSEcCtD
Moclobemide—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000102	0.000853	CcSEcCtD
Moclobemide—Somnolence—Valsartan—type 2 diabetes mellitus	0.000102	0.000852	CcSEcCtD
Moclobemide—Syncope—Losartan—type 2 diabetes mellitus	0.000102	0.000851	CcSEcCtD
Moclobemide—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000101	0.00085	CcSEcCtD
Moclobemide—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000101	0.000849	CcSEcCtD
Moclobemide—MAOB—cortex of kidney—type 2 diabetes mellitus	0.000101	0.0444	CbGeAlD
Moclobemide—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000101	0.000843	CcSEcCtD
Moclobemide—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000101	0.000843	CcSEcCtD
Moclobemide—MAOA—nephron tubule—type 2 diabetes mellitus	0.0001	0.0443	CbGeAlD
Moclobemide—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.0001	0.00084	CcSEcCtD
Moclobemide—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.0001	0.00084	CcSEcCtD
Moclobemide—Palpitations—Losartan—type 2 diabetes mellitus	0.0001	0.000839	CcSEcCtD
Moclobemide—Nausea—Glimepiride—type 2 diabetes mellitus	9.99e-05	0.000836	CcSEcCtD
Moclobemide—Loss of consciousness—Losartan—type 2 diabetes mellitus	9.96e-05	0.000835	CcSEcCtD
Moclobemide—Nausea—Sitagliptin—type 2 diabetes mellitus	9.95e-05	0.000834	CcSEcCtD
Moclobemide—Dyspepsia—Orlistat—type 2 diabetes mellitus	9.95e-05	0.000833	CcSEcCtD
Moclobemide—Asthenia—Glyburide—type 2 diabetes mellitus	9.95e-05	0.000833	CcSEcCtD
Moclobemide—Decreased appetite—Valsartan—type 2 diabetes mellitus	9.94e-05	0.000833	CcSEcCtD
Moclobemide—Urticaria—Gliclazide—type 2 diabetes mellitus	9.89e-05	0.000828	CcSEcCtD
Moclobemide—Fatigue—Valsartan—type 2 diabetes mellitus	9.86e-05	0.000826	CcSEcCtD
Moclobemide—Abdominal pain—Gliclazide—type 2 diabetes mellitus	9.84e-05	0.000824	CcSEcCtD
Moclobemide—Decreased appetite—Orlistat—type 2 diabetes mellitus	9.83e-05	0.000823	CcSEcCtD
Moclobemide—Pruritus—Glyburide—type 2 diabetes mellitus	9.81e-05	0.000822	CcSEcCtD
Moclobemide—Constipation—Valsartan—type 2 diabetes mellitus	9.78e-05	0.000819	CcSEcCtD
Moclobemide—Fatigue—Orlistat—type 2 diabetes mellitus	9.74e-05	0.000816	CcSEcCtD
Moclobemide—Hypotension—Metformin—type 2 diabetes mellitus	9.73e-05	0.000815	CcSEcCtD
Moclobemide—Shock—Irbesartan—type 2 diabetes mellitus	9.67e-05	0.00081	CcSEcCtD
Moclobemide—Myalgia—Losartan—type 2 diabetes mellitus	9.65e-05	0.000808	CcSEcCtD
Moclobemide—Chest pain—Losartan—type 2 diabetes mellitus	9.65e-05	0.000808	CcSEcCtD
Moclobemide—Vomiting—Bromocriptine—type 2 diabetes mellitus	9.64e-05	0.000808	CcSEcCtD
Moclobemide—Anxiety—Losartan—type 2 diabetes mellitus	9.62e-05	0.000806	CcSEcCtD
Moclobemide—Tachycardia—Irbesartan—type 2 diabetes mellitus	9.59e-05	0.000804	CcSEcCtD
Moclobemide—Rash—Bromocriptine—type 2 diabetes mellitus	9.56e-05	0.000801	CcSEcCtD
Moclobemide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	9.55e-05	0.0008	CcSEcCtD
Moclobemide—Tension—Ramipril—type 2 diabetes mellitus	9.54e-05	0.000799	CcSEcCtD
Moclobemide—Discomfort—Losartan—type 2 diabetes mellitus	9.53e-05	0.000799	CcSEcCtD
Moclobemide—Dysgeusia—Ramipril—type 2 diabetes mellitus	9.52e-05	0.000797	CcSEcCtD
Moclobemide—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	9.5e-05	0.000796	CcSEcCtD
Moclobemide—Headache—Bromocriptine—type 2 diabetes mellitus	9.5e-05	0.000796	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	9.49e-05	0.000795	CcSEcCtD
Moclobemide—Diarrhoea—Glyburide—type 2 diabetes mellitus	9.49e-05	0.000795	CcSEcCtD
Moclobemide—Nervousness—Ramipril—type 2 diabetes mellitus	9.44e-05	0.000791	CcSEcCtD
Moclobemide—Dry mouth—Losartan—type 2 diabetes mellitus	9.44e-05	0.000791	CcSEcCtD
Moclobemide—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	9.35e-05	0.000783	CcSEcCtD
Moclobemide—Paraesthesia—Metformin—type 2 diabetes mellitus	9.35e-05	0.000783	CcSEcCtD
Moclobemide—Confusional state—Losartan—type 2 diabetes mellitus	9.33e-05	0.000781	CcSEcCtD
Moclobemide—MAOB—adipose tissue—type 2 diabetes mellitus	9.33e-05	0.0411	CbGeAlD
Moclobemide—Feeling abnormal—Orlistat—type 2 diabetes mellitus	9.31e-05	0.00078	CcSEcCtD
Moclobemide—Dyspnoea—Metformin—type 2 diabetes mellitus	9.29e-05	0.000778	CcSEcCtD
Moclobemide—Somnolence—Metformin—type 2 diabetes mellitus	9.26e-05	0.000776	CcSEcCtD
Moclobemide—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	9.24e-05	0.000774	CcSEcCtD
Moclobemide—Hypotension—Irbesartan—type 2 diabetes mellitus	9.19e-05	0.000769	CcSEcCtD
Moclobemide—Dyspepsia—Metformin—type 2 diabetes mellitus	9.17e-05	0.000768	CcSEcCtD
Moclobemide—Tremor—Ramipril—type 2 diabetes mellitus	9.11e-05	0.000763	CcSEcCtD
Moclobemide—Shock—Losartan—type 2 diabetes mellitus	9.1e-05	0.000762	CcSEcCtD
Moclobemide—Urticaria—Valsartan—type 2 diabetes mellitus	9.09e-05	0.000761	CcSEcCtD
Moclobemide—Decreased appetite—Metformin—type 2 diabetes mellitus	9.05e-05	0.000758	CcSEcCtD
Moclobemide—Abdominal pain—Valsartan—type 2 diabetes mellitus	9.04e-05	0.000757	CcSEcCtD
Moclobemide—Tachycardia—Losartan—type 2 diabetes mellitus	9.03e-05	0.000756	CcSEcCtD
Moclobemide—MAOA—cardiovascular system—type 2 diabetes mellitus	9.02e-05	0.0398	CbGeAlD
Moclobemide—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	9.02e-05	0.000755	CcSEcCtD
Moclobemide—Nausea—Bromocriptine—type 2 diabetes mellitus	9.01e-05	0.000755	CcSEcCtD
Moclobemide—Fatigue—Metformin—type 2 diabetes mellitus	8.98e-05	0.000752	CcSEcCtD
Moclobemide—Urticaria—Orlistat—type 2 diabetes mellitus	8.98e-05	0.000752	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	8.96e-05	0.00075	CcSEcCtD
Moclobemide—Hyperhidrosis—Losartan—type 2 diabetes mellitus	8.94e-05	0.000749	CcSEcCtD
Moclobemide—Abdominal pain—Orlistat—type 2 diabetes mellitus	8.93e-05	0.000748	CcSEcCtD
Moclobemide—Asthenia—Gliclazide—type 2 diabetes mellitus	8.93e-05	0.000748	CcSEcCtD
Moclobemide—Agitation—Ramipril—type 2 diabetes mellitus	8.93e-05	0.000748	CcSEcCtD
Moclobemide—Constipation—Metformin—type 2 diabetes mellitus	8.91e-05	0.000746	CcSEcCtD
Moclobemide—MAOA—kidney—type 2 diabetes mellitus	8.83e-05	0.0389	CbGeAlD
Moclobemide—Paraesthesia—Irbesartan—type 2 diabetes mellitus	8.83e-05	0.000739	CcSEcCtD
Moclobemide—Haloperidol—CYP3A4—type 2 diabetes mellitus	8.82e-05	0.0304	CrCbGaD
Moclobemide—Vomiting—Glyburide—type 2 diabetes mellitus	8.82e-05	0.000738	CcSEcCtD
Moclobemide—Pruritus—Gliclazide—type 2 diabetes mellitus	8.81e-05	0.000738	CcSEcCtD
Moclobemide—MAOA—pancreas—type 2 diabetes mellitus	8.77e-05	0.0386	CbGeAlD
Moclobemide—Malaise—Ramipril—type 2 diabetes mellitus	8.76e-05	0.000734	CcSEcCtD
Moclobemide—Dyspnoea—Irbesartan—type 2 diabetes mellitus	8.76e-05	0.000734	CcSEcCtD
Moclobemide—Rash—Glyburide—type 2 diabetes mellitus	8.74e-05	0.000732	CcSEcCtD
Moclobemide—Somnolence—Irbesartan—type 2 diabetes mellitus	8.74e-05	0.000732	CcSEcCtD
Moclobemide—Dermatitis—Glyburide—type 2 diabetes mellitus	8.73e-05	0.000732	CcSEcCtD
Moclobemide—Syncope—Ramipril—type 2 diabetes mellitus	8.72e-05	0.00073	CcSEcCtD
Moclobemide—Headache—Glyburide—type 2 diabetes mellitus	8.69e-05	0.000728	CcSEcCtD
Moclobemide—Dyspepsia—Irbesartan—type 2 diabetes mellitus	8.65e-05	0.000725	CcSEcCtD
Moclobemide—Hypotension—Losartan—type 2 diabetes mellitus	8.64e-05	0.000724	CcSEcCtD
Moclobemide—MAOA—cortex of kidney—type 2 diabetes mellitus	8.6e-05	0.0379	CbGeAlD
Moclobemide—Palpitations—Ramipril—type 2 diabetes mellitus	8.59e-05	0.000719	CcSEcCtD
Moclobemide—Feeling abnormal—Metformin—type 2 diabetes mellitus	8.58e-05	0.000719	CcSEcCtD
Moclobemide—Decreased appetite—Irbesartan—type 2 diabetes mellitus	8.55e-05	0.000716	CcSEcCtD
Moclobemide—Loss of consciousness—Ramipril—type 2 diabetes mellitus	8.54e-05	0.000716	CcSEcCtD
Moclobemide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	8.52e-05	0.000714	CcSEcCtD
Moclobemide—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	8.52e-05	0.000713	CcSEcCtD
Moclobemide—Fatigue—Irbesartan—type 2 diabetes mellitus	8.47e-05	0.00071	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	8.43e-05	0.000706	CcSEcCtD
Moclobemide—Constipation—Irbesartan—type 2 diabetes mellitus	8.41e-05	0.000704	CcSEcCtD
Moclobemide—Insomnia—Losartan—type 2 diabetes mellitus	8.37e-05	0.000701	CcSEcCtD
Moclobemide—Paraesthesia—Losartan—type 2 diabetes mellitus	8.31e-05	0.000696	CcSEcCtD
Moclobemide—Urticaria—Metformin—type 2 diabetes mellitus	8.27e-05	0.000693	CcSEcCtD
Moclobemide—Myalgia—Ramipril—type 2 diabetes mellitus	8.27e-05	0.000693	CcSEcCtD
Moclobemide—Chest pain—Ramipril—type 2 diabetes mellitus	8.27e-05	0.000693	CcSEcCtD
Moclobemide—Dyspnoea—Losartan—type 2 diabetes mellitus	8.25e-05	0.000691	CcSEcCtD
Moclobemide—Anxiety—Ramipril—type 2 diabetes mellitus	8.25e-05	0.000691	CcSEcCtD
Moclobemide—Nausea—Glyburide—type 2 diabetes mellitus	8.24e-05	0.00069	CcSEcCtD
Moclobemide—Abdominal pain—Metformin—type 2 diabetes mellitus	8.23e-05	0.00069	CcSEcCtD
Moclobemide—Dizziness—Gliclazide—type 2 diabetes mellitus	8.23e-05	0.00069	CcSEcCtD
Moclobemide—Somnolence—Losartan—type 2 diabetes mellitus	8.22e-05	0.000689	CcSEcCtD
Moclobemide—Asthenia—Valsartan—type 2 diabetes mellitus	8.21e-05	0.000687	CcSEcCtD
Moclobemide—Discomfort—Ramipril—type 2 diabetes mellitus	8.18e-05	0.000685	CcSEcCtD
Moclobemide—Dyspepsia—Losartan—type 2 diabetes mellitus	8.14e-05	0.000682	CcSEcCtD
Moclobemide—Asthenia—Orlistat—type 2 diabetes mellitus	8.11e-05	0.000679	CcSEcCtD
Moclobemide—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	8.1e-05	0.000679	CcSEcCtD
Moclobemide—Pruritus—Valsartan—type 2 diabetes mellitus	8.09e-05	0.000678	CcSEcCtD
Moclobemide—Dry mouth—Ramipril—type 2 diabetes mellitus	8.09e-05	0.000678	CcSEcCtD
Moclobemide—Decreased appetite—Losartan—type 2 diabetes mellitus	8.04e-05	0.000674	CcSEcCtD
Moclobemide—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	8.04e-05	0.000673	CcSEcCtD
Moclobemide—Confusional state—Ramipril—type 2 diabetes mellitus	8e-05	0.00067	CcSEcCtD
Moclobemide—Pruritus—Orlistat—type 2 diabetes mellitus	8e-05	0.00067	CcSEcCtD
Moclobemide—Fatigue—Losartan—type 2 diabetes mellitus	7.98e-05	0.000668	CcSEcCtD
Moclobemide—MAOA—adipose tissue—type 2 diabetes mellitus	7.96e-05	0.0351	CbGeAlD
Moclobemide—Vomiting—Gliclazide—type 2 diabetes mellitus	7.92e-05	0.000663	CcSEcCtD
Moclobemide—Constipation—Losartan—type 2 diabetes mellitus	7.91e-05	0.000663	CcSEcCtD
Moclobemide—Rash—Gliclazide—type 2 diabetes mellitus	7.85e-05	0.000658	CcSEcCtD
Moclobemide—Dermatitis—Gliclazide—type 2 diabetes mellitus	7.84e-05	0.000657	CcSEcCtD
Moclobemide—Diarrhoea—Valsartan—type 2 diabetes mellitus	7.83e-05	0.000656	CcSEcCtD
Moclobemide—Urticaria—Irbesartan—type 2 diabetes mellitus	7.81e-05	0.000654	CcSEcCtD
Moclobemide—Shock—Ramipril—type 2 diabetes mellitus	7.8e-05	0.000654	CcSEcCtD
Moclobemide—Headache—Gliclazide—type 2 diabetes mellitus	7.8e-05	0.000653	CcSEcCtD
Moclobemide—Abdominal pain—Irbesartan—type 2 diabetes mellitus	7.77e-05	0.000651	CcSEcCtD
Moclobemide—Tachycardia—Ramipril—type 2 diabetes mellitus	7.74e-05	0.000648	CcSEcCtD
Moclobemide—Diarrhoea—Orlistat—type 2 diabetes mellitus	7.73e-05	0.000648	CcSEcCtD
Moclobemide—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	7.67e-05	0.000642	CcSEcCtD
Moclobemide—Feeling abnormal—Losartan—type 2 diabetes mellitus	7.62e-05	0.000639	CcSEcCtD
Moclobemide—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	7.56e-05	0.000634	CcSEcCtD
Moclobemide—Dizziness—Valsartan—type 2 diabetes mellitus	7.56e-05	0.000634	CcSEcCtD
Moclobemide—Dizziness—Orlistat—type 2 diabetes mellitus	7.47e-05	0.000626	CcSEcCtD
Moclobemide—Asthenia—Metformin—type 2 diabetes mellitus	7.47e-05	0.000626	CcSEcCtD
Moclobemide—Hypotension—Ramipril—type 2 diabetes mellitus	7.41e-05	0.000621	CcSEcCtD
Moclobemide—Nausea—Gliclazide—type 2 diabetes mellitus	7.4e-05	0.000619	CcSEcCtD
Moclobemide—Pruritus—Metformin—type 2 diabetes mellitus	7.37e-05	0.000617	CcSEcCtD
Moclobemide—Urticaria—Losartan—type 2 diabetes mellitus	7.35e-05	0.000616	CcSEcCtD
Moclobemide—Abdominal pain—Losartan—type 2 diabetes mellitus	7.31e-05	0.000613	CcSEcCtD
Moclobemide—Vomiting—Valsartan—type 2 diabetes mellitus	7.27e-05	0.000609	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	7.23e-05	0.000605	CcSEcCtD
Moclobemide—Rash—Valsartan—type 2 diabetes mellitus	7.21e-05	0.000604	CcSEcCtD
Moclobemide—Dermatitis—Valsartan—type 2 diabetes mellitus	7.21e-05	0.000604	CcSEcCtD
Moclobemide—Vomiting—Orlistat—type 2 diabetes mellitus	7.19e-05	0.000602	CcSEcCtD
Moclobemide—Insomnia—Ramipril—type 2 diabetes mellitus	7.17e-05	0.000601	CcSEcCtD
Moclobemide—Headache—Valsartan—type 2 diabetes mellitus	7.17e-05	0.0006	CcSEcCtD
Moclobemide—CYP2C9—cardiovascular system—type 2 diabetes mellitus	7.15e-05	0.0315	CbGeAlD
Moclobemide—Diarrhoea—Metformin—type 2 diabetes mellitus	7.13e-05	0.000597	CcSEcCtD
Moclobemide—Rash—Orlistat—type 2 diabetes mellitus	7.13e-05	0.000597	CcSEcCtD
Moclobemide—Paraesthesia—Ramipril—type 2 diabetes mellitus	7.12e-05	0.000597	CcSEcCtD
Moclobemide—Dermatitis—Orlistat—type 2 diabetes mellitus	7.12e-05	0.000596	CcSEcCtD
Moclobemide—Headache—Orlistat—type 2 diabetes mellitus	7.08e-05	0.000593	CcSEcCtD
Moclobemide—Dyspnoea—Ramipril—type 2 diabetes mellitus	7.07e-05	0.000592	CcSEcCtD
Moclobemide—Asthenia—Irbesartan—type 2 diabetes mellitus	7.05e-05	0.000591	CcSEcCtD
Moclobemide—Somnolence—Ramipril—type 2 diabetes mellitus	7.05e-05	0.000591	CcSEcCtD
Moclobemide—Dyspepsia—Ramipril—type 2 diabetes mellitus	6.98e-05	0.000585	CcSEcCtD
Moclobemide—Pruritus—Irbesartan—type 2 diabetes mellitus	6.95e-05	0.000583	CcSEcCtD
Moclobemide—Decreased appetite—Ramipril—type 2 diabetes mellitus	6.9e-05	0.000578	CcSEcCtD
Moclobemide—Dizziness—Metformin—type 2 diabetes mellitus	6.89e-05	0.000577	CcSEcCtD
Moclobemide—Fatigue—Ramipril—type 2 diabetes mellitus	6.84e-05	0.000573	CcSEcCtD
Moclobemide—Nausea—Valsartan—type 2 diabetes mellitus	6.79e-05	0.000569	CcSEcCtD
Moclobemide—Constipation—Ramipril—type 2 diabetes mellitus	6.78e-05	0.000568	CcSEcCtD
Moclobemide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	6.73e-05	0.000563	CcSEcCtD
Moclobemide—Nausea—Orlistat—type 2 diabetes mellitus	6.71e-05	0.000562	CcSEcCtD
Moclobemide—Asthenia—Losartan—type 2 diabetes mellitus	6.64e-05	0.000556	CcSEcCtD
Moclobemide—Vomiting—Metformin—type 2 diabetes mellitus	6.62e-05	0.000555	CcSEcCtD
Moclobemide—Rash—Metformin—type 2 diabetes mellitus	6.57e-05	0.00055	CcSEcCtD
Moclobemide—Dermatitis—Metformin—type 2 diabetes mellitus	6.56e-05	0.00055	CcSEcCtD
Moclobemide—Pruritus—Losartan—type 2 diabetes mellitus	6.54e-05	0.000548	CcSEcCtD
Moclobemide—MAOB—liver—type 2 diabetes mellitus	6.54e-05	0.0288	CbGeAlD
Moclobemide—Feeling abnormal—Ramipril—type 2 diabetes mellitus	6.54e-05	0.000548	CcSEcCtD
Moclobemide—Headache—Metformin—type 2 diabetes mellitus	6.53e-05	0.000547	CcSEcCtD
Moclobemide—Dizziness—Irbesartan—type 2 diabetes mellitus	6.5e-05	0.000544	CcSEcCtD
Moclobemide—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	6.49e-05	0.000543	CcSEcCtD
Moclobemide—Diarrhoea—Losartan—type 2 diabetes mellitus	6.33e-05	0.00053	CcSEcCtD
Moclobemide—Urticaria—Ramipril—type 2 diabetes mellitus	6.3e-05	0.000528	CcSEcCtD
Moclobemide—Abdominal pain—Ramipril—type 2 diabetes mellitus	6.27e-05	0.000525	CcSEcCtD
Moclobemide—Vomiting—Irbesartan—type 2 diabetes mellitus	6.25e-05	0.000524	CcSEcCtD
Moclobemide—Rash—Irbesartan—type 2 diabetes mellitus	6.2e-05	0.000519	CcSEcCtD
Moclobemide—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.19e-05	0.000519	CcSEcCtD
Moclobemide—Nausea—Metformin—type 2 diabetes mellitus	6.19e-05	0.000518	CcSEcCtD
Moclobemide—Headache—Irbesartan—type 2 diabetes mellitus	6.16e-05	0.000516	CcSEcCtD
Moclobemide—Dizziness—Losartan—type 2 diabetes mellitus	6.12e-05	0.000512	CcSEcCtD
Moclobemide—Vomiting—Losartan—type 2 diabetes mellitus	5.88e-05	0.000493	CcSEcCtD
Moclobemide—Nausea—Irbesartan—type 2 diabetes mellitus	5.84e-05	0.000489	CcSEcCtD
Moclobemide—Rash—Losartan—type 2 diabetes mellitus	5.83e-05	0.000489	CcSEcCtD
Moclobemide—Dermatitis—Losartan—type 2 diabetes mellitus	5.83e-05	0.000488	CcSEcCtD
Moclobemide—Headache—Losartan—type 2 diabetes mellitus	5.8e-05	0.000485	CcSEcCtD
Moclobemide—CYP2C19—liver—type 2 diabetes mellitus	5.7e-05	0.0251	CbGeAlD
Moclobemide—Asthenia—Ramipril—type 2 diabetes mellitus	5.69e-05	0.000477	CcSEcCtD
Moclobemide—Pruritus—Ramipril—type 2 diabetes mellitus	5.61e-05	0.00047	CcSEcCtD
Moclobemide—MAOA—liver—type 2 diabetes mellitus	5.58e-05	0.0246	CbGeAlD
Moclobemide—Nausea—Losartan—type 2 diabetes mellitus	5.49e-05	0.00046	CcSEcCtD
Moclobemide—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.43e-05	0.000455	CcSEcCtD
Moclobemide—CYP2D6—kidney—type 2 diabetes mellitus	5.25e-05	0.0231	CbGeAlD
Moclobemide—Dizziness—Ramipril—type 2 diabetes mellitus	5.25e-05	0.000439	CcSEcCtD
Moclobemide—Vomiting—Ramipril—type 2 diabetes mellitus	5.04e-05	0.000422	CcSEcCtD
Moclobemide—Rash—Ramipril—type 2 diabetes mellitus	5e-05	0.000419	CcSEcCtD
Moclobemide—Dermatitis—Ramipril—type 2 diabetes mellitus	5e-05	0.000419	CcSEcCtD
Moclobemide—Headache—Ramipril—type 2 diabetes mellitus	4.97e-05	0.000416	CcSEcCtD
Moclobemide—Nausea—Ramipril—type 2 diabetes mellitus	4.71e-05	0.000395	CcSEcCtD
Moclobemide—CYP1A2—liver—type 2 diabetes mellitus	4.66e-05	0.0205	CbGeAlD
Moclobemide—CYP2C9—liver—type 2 diabetes mellitus	4.42e-05	0.0195	CbGeAlD
Moclobemide—CYP2D6—liver—type 2 diabetes mellitus	3.32e-05	0.0146	CbGeAlD
Moclobemide—CYP1A2—Metabolism—NCOA6—type 2 diabetes mellitus	7.28e-06	0.000165	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	7.27e-06	0.000165	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	7.27e-06	0.000165	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—MTHFR—type 2 diabetes mellitus	7.2e-06	0.000163	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	7.18e-06	0.000163	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	7.18e-06	0.000163	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	7.18e-06	0.000163	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	7.18e-06	0.000163	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—UCP2—type 2 diabetes mellitus	7.15e-06	0.000162	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—UCP3—type 2 diabetes mellitus	7.15e-06	0.000162	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—HSD11B1—type 2 diabetes mellitus	7.15e-06	0.000162	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	7.12e-06	0.000161	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	7.12e-06	0.000161	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	7.12e-06	0.000161	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	7.12e-06	0.000161	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	7.12e-06	0.000161	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PPARA—type 2 diabetes mellitus	7.06e-06	0.00016	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	7.04e-06	0.000159	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GLP1R—type 2 diabetes mellitus	6.96e-06	0.000158	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	6.93e-06	0.000157	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	6.88e-06	0.000156	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	6.84e-06	0.000155	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—AGT—type 2 diabetes mellitus	6.84e-06	0.000155	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	6.82e-06	0.000155	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PCK1—type 2 diabetes mellitus	6.73e-06	0.000152	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CALM1—type 2 diabetes mellitus	6.73e-06	0.000152	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—APOE—type 2 diabetes mellitus	6.7e-06	0.000152	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	6.63e-06	0.00015	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—APOA1—type 2 diabetes mellitus	6.62e-06	0.00015	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	6.62e-06	0.00015	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—SLC2A2—type 2 diabetes mellitus	6.5e-06	0.000147	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	6.49e-06	0.000147	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	6.46e-06	0.000146	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	6.42e-06	0.000145	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	6.4e-06	0.000145	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CPT1A—type 2 diabetes mellitus	6.36e-06	0.000144	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—MTR—type 2 diabetes mellitus	6.36e-06	0.000144	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	6.34e-06	0.000144	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	6.3e-06	0.000143	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	6.29e-06	0.000142	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—NAMPT—type 2 diabetes mellitus	6.24e-06	0.000141	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	6.2e-06	0.00014	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—HBA1—type 2 diabetes mellitus	6.2e-06	0.00014	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GCK—type 2 diabetes mellitus	6.2e-06	0.00014	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—LIPC—type 2 diabetes mellitus	6.2e-06	0.00014	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP11A1—type 2 diabetes mellitus	6.16e-06	0.00014	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	6.08e-06	0.000138	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	6.08e-06	0.000138	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	6.08e-06	0.000138	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	6.08e-06	0.000138	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—SLC9A1—type 2 diabetes mellitus	6.05e-06	0.000137	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CETP—type 2 diabetes mellitus	5.98e-06	0.000135	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	5.97e-06	0.000135	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	5.92e-06	0.000134	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	5.85e-06	0.000133	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	5.85e-06	0.000133	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	5.85e-06	0.000132	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PPARG—type 2 diabetes mellitus	5.84e-06	0.000132	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	5.83e-06	0.000132	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	5.8e-06	0.000131	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	5.8e-06	0.000131	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	5.74e-06	0.00013	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—INS—type 2 diabetes mellitus	5.73e-06	0.00013	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	5.7e-06	0.000129	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	5.7e-06	0.000129	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	5.7e-06	0.000129	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	5.69e-06	0.000129	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	5.67e-06	0.000128	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	5.66e-06	0.000128	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	5.66e-06	0.000128	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	5.65e-06	0.000128	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	5.65e-06	0.000128	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	5.65e-06	0.000128	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	5.62e-06	0.000127	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.58e-06	0.000126	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	5.57e-06	0.000126	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	5.56e-06	0.000126	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	5.56e-06	0.000126	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	5.56e-06	0.000126	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	5.55e-06	0.000126	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	5.52e-06	0.000125	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	5.5e-06	0.000125	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	5.49e-06	0.000124	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	5.46e-06	0.000124	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	5.46e-06	0.000124	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	5.42e-06	0.000123	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	5.41e-06	0.000123	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.34e-06	0.000121	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	5.3e-06	0.00012	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ALB—type 2 diabetes mellitus	5.25e-06	0.000119	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	5.12e-06	0.000116	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	5.12e-06	0.000116	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	5.12e-06	0.000116	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	5.09e-06	0.000115	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.09e-06	0.000115	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	5.07e-06	0.000115	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	5.07e-06	0.000115	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	5.07e-06	0.000115	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	5.06e-06	0.000115	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	5.03e-06	0.000114	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	5.03e-06	0.000114	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	5.02e-06	0.000114	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PIK3R1—type 2 diabetes mellitus	5.02e-06	0.000114	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—NOS3—type 2 diabetes mellitus	5.02e-06	0.000114	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	4.98e-06	0.000113	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	4.98e-06	0.000113	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	4.96e-06	0.000112	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	4.96e-06	0.000112	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	4.93e-06	0.000112	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	4.91e-06	0.000111	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.88e-06	0.000111	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	4.87e-06	0.00011	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.87e-06	0.00011	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	4.86e-06	0.00011	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	4.83e-06	0.000109	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	4.83e-06	0.000109	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	4.83e-06	0.000109	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	4.83e-06	0.000109	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	4.83e-06	0.000109	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	4.82e-06	0.000109	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	4.82e-06	0.000109	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	4.8e-06	0.000109	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	4.72e-06	0.000107	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	4.68e-06	0.000106	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	4.66e-06	0.000106	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	4.64e-06	0.000105	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	4.63e-06	0.000105	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	4.63e-06	0.000105	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PTGS2—type 2 diabetes mellitus	4.59e-06	0.000104	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	4.59e-06	0.000104	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	4.59e-06	0.000104	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	4.51e-06	0.000102	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	4.47e-06	0.000101	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.45e-06	0.000101	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	4.44e-06	0.0001	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	4.44e-06	0.0001	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	4.4e-06	9.96e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	4.4e-06	9.96e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.35e-06	9.84e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	4.33e-06	9.81e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	4.33e-06	9.81e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	4.33e-06	9.81e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	4.25e-06	9.63e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	4.22e-06	9.55e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.16e-06	9.42e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.16e-06	9.41e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	4.16e-06	9.41e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	4.14e-06	9.37e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	4.13e-06	9.34e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	4.08e-06	9.24e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	3.96e-06	8.98e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	3.96e-06	8.97e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	3.92e-06	8.88e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	3.86e-06	8.73e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	3.82e-06	8.66e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.82e-06	8.66e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	3.82e-06	8.66e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	3.81e-06	8.62e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.8e-06	8.61e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.79e-06	8.58e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	3.79e-06	8.58e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	3.78e-06	8.57e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	3.77e-06	8.54e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	3.76e-06	8.51e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	3.76e-06	8.51e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	3.76e-06	8.5e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	3.72e-06	8.43e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	3.7e-06	8.39e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	3.69e-06	8.36e-05	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—AKT1—type 2 diabetes mellitus	3.68e-06	8.33e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	3.65e-06	8.25e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	3.61e-06	8.18e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	3.6e-06	8.14e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	3.55e-06	8.04e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	3.55e-06	8.03e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	3.52e-06	7.96e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	3.48e-06	7.88e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	3.45e-06	7.81e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	3.41e-06	7.72e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	3.41e-06	7.72e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	3.4e-06	7.69e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	3.38e-06	7.65e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	3.37e-06	7.62e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	3.34e-06	7.57e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	3.31e-06	7.49e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	3.28e-06	7.42e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	3.27e-06	7.4e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.24e-06	7.33e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	3.24e-06	7.33e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	3.24e-06	7.33e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	3.24e-06	7.33e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	3.22e-06	7.3e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	3.18e-06	7.21e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	3.18e-06	7.2e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	3.17e-06	7.18e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	3.14e-06	7.1e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	3.13e-06	7.1e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	3.11e-06	7.04e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	3.09e-06	6.99e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	3.07e-06	6.96e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	3.05e-06	6.9e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	3e-06	6.8e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	2.98e-06	6.74e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	2.95e-06	6.68e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	2.95e-06	6.68e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	2.93e-06	6.63e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	2.92e-06	6.61e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	2.9e-06	6.57e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	2.89e-06	6.55e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	2.89e-06	6.54e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	2.88e-06	6.53e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	2.88e-06	6.51e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	2.86e-06	6.47e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	2.8e-06	6.34e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.77e-06	6.27e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	2.76e-06	6.26e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	2.71e-06	6.14e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	2.65e-06	6.01e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	2.6e-06	5.9e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	2.54e-06	5.75e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	2.52e-06	5.71e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	2.52e-06	5.71e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	2.49e-06	5.64e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	2.48e-06	5.63e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	2.48e-06	5.62e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	2.47e-06	5.6e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	2.47e-06	5.6e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	2.44e-06	5.53e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	2.38e-06	5.38e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	2.38e-06	5.38e-05	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—AKT1—type 2 diabetes mellitus	2.31e-06	5.23e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	2.29e-06	5.17e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	2.27e-06	5.13e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	2.19e-06	4.95e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.19e-06	4.95e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	2.17e-06	4.92e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	2.17e-06	4.91e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	2.17e-06	4.91e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	2.15e-06	4.88e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	2.11e-06	4.78e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	2e-06	4.53e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.98e-06	4.49e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.94e-06	4.38e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.85e-06	4.19e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.85e-06	4.19e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.69e-06	3.84e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	1.09e-06	2.47e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1e-06	2.28e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	9.96e-07	2.26e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	8.51e-07	1.93e-05	CbGpPWpGaD
